Poveda JL - Search Results

1

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments.

Gómez-Cebrián N, Domingo-Ortí I, Poveda JL, Vicent MJ, Puchades-Carrasco L, Pineda-Lucena A. Gómez-Cebrián N, et al. Among authors: poveda jl. Cancers (Basel). 2021 Sep 10;13(18):4544. doi: 10.3390/cancers13184544. Cancers (Basel). 2021. PMID: 34572770 Free PMC article. Review.

2

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gómez-Cebrián N, Poveda JL, Pineda-Lucena A, Puchades-Carrasco L. Gómez-Cebrián N, et al. Among authors: poveda jl. Cancers (Basel). 2022 Jan 25;14(3):596. doi: 10.3390/cancers14030596. Cancers (Basel). 2022. PMID: 35158864 Free PMC article. Review.

3

SNPs and taxane toxicity in breast cancer patients.

Bosó V, Herrero MJ, Santaballa A, Palomar L, Megias JE, de la Cueva H, Rojas L, Marqués MR, Poveda JL, Montalar J, Aliño SF. Bosó V, et al. Among authors: poveda jl. Pharmacogenomics. 2014;15(15):1845-58. doi: 10.2217/pgs.14.127. Pharmacogenomics. 2014. PMID: 25495407

4

In utero exposure to mycophenolate mofetil: a characteristic phenotype?

Perez-Aytes A, Ledo A, Boso V, Sáenz P, Roma E, Poveda JL, Vento M. Perez-Aytes A, et al. Among authors: poveda jl. Am J Med Genet A. 2008 Jan 1;146A(1):1-7. doi: 10.1002/ajmg.a.32117. Am J Med Genet A. 2008. PMID: 18074358

5

Clinical interest of pharmacogenetic polymorphisms in the immunosuppressive treatment after heart transplantation.

Herrero MJ, Almenar L, Jordán C, Sánchez I, Poveda JL, Aliño SF. Herrero MJ, et al. Among authors: poveda jl. Transplant Proc. 2010 Oct;42(8):3181-2. doi: 10.1016/j.transproceed.2010.05.129. Transplant Proc. 2010. PMID: 20970643

6

Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.

Bosó V, Herrero MJ, Bea S, Galiana M, Marrero P, Marqués MR, Hernández J, Sánchez-Plumed J, Poveda JL, Aliño SF. Bosó V, et al. Among authors: poveda jl. Drug Metab Dispos. 2013 Feb;41(2):480-7. doi: 10.1124/dmd.112.047977. Epub 2012 Nov 21. Drug Metab Dispos. 2013. PMID: 23175667

7

Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE, Herrero MJ, Bosó V, García-Eliz M, Poveda JL, Librero J, Aliño SF. Rojas LE, et al. Among authors: poveda jl. Pharmacogenet Genomics. 2013 Oct;23(10):509-17. doi: 10.1097/FPC.0b013e3283642fb3. Pharmacogenet Genomics. 2013. PMID: 23873120 Review.

8

Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.

Bosó V, Herrero MJ, Buso E, Galán J, Almenar L, Sánchez-Lázaro I, Sánchez-Plumed J, Bea S, Prieto M, García M, Pastor A, Sole A, Poveda JL, Aliño SF. Bosó V, et al. Among authors: poveda jl. Ther Drug Monit. 2014 Apr;36(2):159-68. doi: 10.1097/FTD.0b013e3182a94e65. Ther Drug Monit. 2014. PMID: 24232128

9

Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.

Ruiz Ramos J, Roma E, Palomar L, Poveda JL. Ruiz Ramos J, et al. Among authors: poveda jl. Chemotherapy. 2013;59(5):344-5. doi: 10.1159/000360691. Epub 2014 May 9. Chemotherapy. 2013. PMID: 24820861

10

Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies.

Rojas L, Neumann I, Herrero MJ, Bosó V, Reig J, Poveda JL, Megías J, Bea S, Aliño SF. Rojas L, et al. Among authors: poveda jl. Pharmacogenomics J. 2015 Feb;15(1):38-48. doi: 10.1038/tpj.2014.38. Epub 2014 Sep 9. Pharmacogenomics J. 2015. PMID: 25201288 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page